Pharmaceutical

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmaceuticals for Staphylococcus aureus Infections: Likelihood of Approval

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III for Staphylococcus aureus Infections.

Feb 8, 2024 - 18:00
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical development by Citius Pharmaceuticals and currently in Phase III for Staphylococcus aureus Infections.
Read the original article

Tags:

Previous Article

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmac...

Next Article

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) by Citius Pharmac...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

STAT+: In surprise move, FDA calls for advisory committ...

Mar 8, 2024

STAT+: Sen. Cassidy wants to put a stop to FDA delays in drug review process

STAT+: Sen. Cassidy wants to put a stop to FDA delays i...

Jun 8, 2023

STAT+: Merck to acquire Prometheus Biosciences, maker of autoimmune drugs, for $10.8 billion

STAT+: Merck to acquire Prometheus Biosciences, maker o...

Apr 17, 2023